R
Retina Consultants of Charleston | Retina Research of Beaufort
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KSI-301
Aflibercept
Avacincaptad pegol
Zimura
Parent organization
This site is a part of Retina Consultants of Charleston
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) w...
Active, not recruiting
Age-Related Macular Degeneration
Geographic Atrophy
Drug: avacincaptad pegol
RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AM...
Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: RGX-314 Dose 2
Biological: Aflibercept (EYLEA®)
Trial sponsors
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems